Ming Yang1, Minghui Yao1, Gang Wang1, Cangsong Xiao1, Yang Wu1, Huajun Zhang1, Changqing Gao2. 1. Department of Cardiovascular Surgery, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China. 2. Department of Cardiovascular Surgery, Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China. Electronic address: gaochq301@gmail.com.
Abstract
BACKGROUND: Robotically assisted cardiac surgery is an alternative to conventional, open-chest surgery. Although studies have been done on the clinical effect, morbidity, and mortality of robotically assisted atrial myxoma excision, few have addressed surgical outcomes, such as pain, quality of life (QOL), and length of sick leave from work. In this study, our aim was to evaluate these clinical variables among patients after they undergo robotically assisted atrial myxoma excision surgery. METHODS: Between January 2007 and January 2013, a total of 93 patients underwent either conventional sternotomy or robotically assisted atrial myxoma excision in our unit. The 36-item Medical Outcomes Study Short Form Survey was used to assess the clinical outcomes in these patients postoperatively, at day 30 and 6 months. RESULTS: The QOL scores for 7 of 8 variables in the robotically assisted group were significantly higher than those in the conventional group at postoperative day 30 (P < .05). The degree of pain and its influence on work or life was lower in the robotically assisted group (P < .05), and these patients returned to work after 0.9 ± 0.1 months, whereas those in the conventional group needed a sick leave of 3.3 ± 0.4 months. CONCLUSIONS: The level of restoration of normal QOL within 30 days after atrial myxoma surgery is excellent with the robotically assisted approach, which may enable early return to employment and satisfactory recovery.
BACKGROUND: Robotically assisted cardiac surgery is an alternative to conventional, open-chest surgery. Although studies have been done on the clinical effect, morbidity, and mortality of robotically assisted atrial myxoma excision, few have addressed surgical outcomes, such as pain, quality of life (QOL), and length of sick leave from work. In this study, our aim was to evaluate these clinical variables among patients after they undergo robotically assisted atrial myxoma excision surgery. METHODS: Between January 2007 and January 2013, a total of 93 patients underwent either conventional sternotomy or robotically assisted atrial myxoma excision in our unit. The 36-item Medical Outcomes Study Short Form Survey was used to assess the clinical outcomes in these patients postoperatively, at day 30 and 6 months. RESULTS: The QOL scores for 7 of 8 variables in the robotically assisted group were significantly higher than those in the conventional group at postoperative day 30 (P < .05). The degree of pain and its influence on work or life was lower in the robotically assisted group (P < .05), and these patients returned to work after 0.9 ± 0.1 months, whereas those in the conventional group needed a sick leave of 3.3 ± 0.4 months. CONCLUSIONS: The level of restoration of normal QOL within 30 days after atrial myxoma surgery is excellent with the robotically assisted approach, which may enable early return to employment and satisfactory recovery.
Authors: Haizhi Zhao; Huajun Zhang; Ming Yang; Cangsong Xiao; Yao Wang; Changqing Gao; Rong Wang Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2020-11-30
Authors: Makoto Mori; Suveen Angraal; Sarwat I Chaudhry; Lisa G Suter; Arnar Geirsson; Joshua D Wallach; Harlan M Krumholz Journal: J Am Heart Assoc Date: 2019-10-16 Impact factor: 5.501